0905_Ducasse.pdf

《0905_Ducasse.pdf》由会员分享，可在线阅读，更多相关《0905_Ducasse.pdf（27页珍藏版）》请在三个皮匠报告上搜索。

1、11-13 December 2025Carrousel du Louvre,Paris#PVI25THERAPY OF CHOICE FOR DIFFERENT LESION CHARACTERISTICS:cases examples and my algorithmE Ducasse,X Brard,C CaraduUnit of vascular&endovascular surgeryStatement of financial interest2I currently have,or have had over the last two years,an affiliation o

2、r financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company:Speakers name:Pr Eric DucasseI currently have no conflict of interest for this presentationBACKGROUND340 years of progressBest treatment?Strong algorythm?ALGO

3、RYTHM-Long termefficacy?-Per operativetime consuming?-Cost/efficacy?-Reprobucibility?-Clinicalimprovementneeded?4TO ACCESSTO CROSSTO PREPARETO TREATCFA access most of time+/-hybridBrachial if needed0.035 guidewire+support catheter0.0018 guidewire(crossing)+catheterReentry devices:never!/CO or brachi

4、alProgressive angioplastyLong angioplasty length and timingDEB?IVL?CERAB or V-stenting?Covered stentsSelf expending stentKEYPOINTS Two main keypoints for the aorto-iliac treatment:Outflow:CFA/PFA/SFA Aorta quality:5Exact evaluation of lesionsCoral reef decreased flowGlobal Leriche AAA with thrombus3

5、 REVOLUTIONS IN AORTO ILIAC LESIONSduring last 10 years Accesses/techniques and guidewire/support catheter for CROSSING Use of COVERED STENT+/-nitinol stents Use of IVL6Covered stents Advanta V12 has touched 500,000 lives First contact with covered balloon expandable stents the first balloon expanda

6、ble covered stent with long-term real-world data Advantages of Covered Stents:Mechanical barrier to:ISREmbolisationRisk of rupture 7TTT of Aorto-iliac occlusive Diseasegreatestnumber of TASC D lesionstreatedin trialsCOBEST(V12 vs BMS)prospective,multicenter,RCT125 patients(168 iliac arteries)withsev